Physician profile
Supriti Paul
NPI 1316063936
$1,236.36
in general payments reported to CMS, 2019-2025
16 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.83 · 2021: $173 · 2022: $147 · 2023: $446 · 2024: $295 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $324.26 | 2019-2024 | |
| Stryker Corporation | $203.62 | 2022-2023 | Scopis Ent |
| Smith+Nephew, INC. | $190.86 | 2023-2025 | Tula, Halo |
| Ethicon US, LLC | $84.97 | 2021 | |
| Neurent Medical Limited | $76.66 | 2022-2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Inspire Medical Systems, INC. | $58.20 | 2023-2024 | Inspire |
| Glaxosmithkline, LLC. | $54.03 | 2023-2024 | Nucala |
| Aerin Medical INC. | $48.52 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $39.31 | 2021 | |
| Optinose US, INC. | $38.07 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $29.52 | 2021 | |
| Medtronic, INC. | $20.08 | 2023 | Sinuva |
| Alk-Abello, INC | $19.43 | 2023 | Grastek, Odactra, Ragwitek |
| Merck Sharp & Dohme LLC | $19.40 | 2021 | |
| Itamar Medical INC | $15.73 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Supriti Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.